| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082504 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081693 Capable of releasing the drug at a constant rate following zero order kinetics for 24 hours or more |
| 04/29/2004 | US20040081675 Cosmetic formulations containing flavonoid derivatives |
| 04/29/2004 | US20040081651 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/29/2004 | US20040081650 Inflammatory mediator antagonists |
| 04/29/2004 | US20040081648 Adzymes and uses thereof |
| 04/29/2004 | US20040081647 For inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide |
| 04/29/2004 | US20040081635 Antiinflammatory agents; anticancer agents; bactericides; fungicides; autoimmune diseases; mixture of interferons with carriers |
| 04/29/2004 | US20040081624 Mixture containing high volatility carrier; vaporization; mixing with air |
| 04/29/2004 | CA2542507A1 Treatment of inflammatory bowel disease |
| 04/29/2004 | CA2502644A1 Reverse-turn mimetics and composition and methods relating thereto |
| 04/29/2004 | CA2501093A1 Combinations of benzodithiazoles and cox-2 inhibitors for the treatment of pain |
| 04/29/2004 | CA2500987A1 Dosage form of sodium ibuprofen |
| 04/29/2004 | CA2500083A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 04/28/2004 | EP1413583A2 Compounds that inhibit T cell proliferation and methods using the same |
| 04/28/2004 | EP1413581A1 Rapamycin derivatives |
| 04/28/2004 | EP1413307A1 Therapeutically active levorotatory and dextrorotatory 1-(4-chlorophenyl)phenylmethyl piperazines |
| 04/28/2004 | EP1413306A1 Tetrahydroquinoline derivatives as CRTH2 antagonists |
| 04/28/2004 | EP1413297A1 Cyclosporin-containing soft capsule preparations |
| 04/28/2004 | EP1413295A1 Sustained release composition for oral administration of drugs |
| 04/28/2004 | EP1412503A2 A fusion protein |
| 04/28/2004 | EP1412499A2 Cytokine polypeptides |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412492A2 Regulator of calcineurin |
| 04/28/2004 | EP1412482A2 Uses of opg ligand to modulate immune responses |
| 04/28/2004 | EP1412370A1 Nucleoside pyrophosphate and triphosphate analogs and related compounds as therapeutic agents |
| 04/28/2004 | EP1412362A1 Chemical compounds |
| 04/28/2004 | EP1412361A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 04/28/2004 | EP1412360A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 04/28/2004 | EP1412353A1 Imidazopyridinones as p38 map kinase inhibitors |
| 04/28/2004 | EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP1412320A1 Linked cyclitols and their polysulfated derivatives |
| 04/28/2004 | EP1412317A1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities |
| 04/28/2004 | EP1411983A1 Bispecific antibodies that bind to vegf receptors |
| 04/28/2004 | EP1411970A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/28/2004 | EP1411967A2 Blocking peptide for inflammatory cell secretion |
| 04/28/2004 | EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1411919A1 (-)-olivil as antioxidant |
| 04/28/2004 | EP1411913A1 Antimicrobial nanoemulsion compositions and methods |
| 04/28/2004 | EP1411912A1 Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411905A1 Sustained release delivery system |
| 04/28/2004 | EP1411904A1 Sustained release pharmaceutical composition |
| 04/28/2004 | EP1411900A2 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 04/28/2004 | EP1411899A2 Taste masking composition |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411890A1 Cosmetic and/or pharmaceutical preparations containing plant extracts |
| 04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263715B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263714B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1244642B1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 04/28/2004 | EP1230237B1 Magnesium omeprazole |
| 04/28/2004 | EP1227098B1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 04/28/2004 | EP1208096B1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 04/28/2004 | EP1206448B1 Novel vitamin d analogues |
| 04/28/2004 | EP1126829B1 Particles coated with granulated crystalline ibuprofen |
| 04/28/2004 | EP1087970B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/28/2004 | EP1083171B1 Pyrazoline derivatives, their preparation and application as medicaments |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/28/2004 | EP0782455B1 Use of porphyrins in the treatment of multiple sclerosis |
| 04/28/2004 | EP0719253B1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 04/28/2004 | CN1491710A Golden buckwheat rhizome preparation and its producing method and use |
| 04/28/2004 | CN1491692A Red medicine thin film coating tablet |
| 04/28/2004 | CN1491680A Poria pill |
| 04/28/2004 | CN1491679A Prepared aconite root drink |
| 04/28/2004 | CN1491675A Medicine for treating cow mammitis |
| 04/28/2004 | CN1491663A Oral administration preparation of total red peoniforin and its preparing method |
| 04/28/2004 | CN1491662A Injection of total red penoniforin and its preparing method |
| 04/28/2004 | CN1491657A Medicinal composition for injection, preparation containing said medicinal composition and its preparing process |
| 04/28/2004 | CN1491645A Compound preparation for improving acute wound heeling for local use |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/28/2004 | CN1147495C Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 04/28/2004 | CN1147492C New metal protease inhibitors its preparing method and their medicinal composition containing them |
| 04/28/2004 | CN1147486C 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
| 04/28/2004 | CN1147483C Adamantane derivatives |
| 04/28/2004 | CN1147481C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 04/28/2004 | CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 04/28/2004 | CN1147311C External-use medicine for treating sore ulcer, wound, rheumatism and other diseases and its preparation |
| 04/28/2004 | CN1147308C Plaster for treating bone diseases |
| 04/28/2004 | CN1147300C Vitronectin receptor antagonist |
| 04/28/2004 | CN1147295C Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof and its preparation |
| 04/27/2004 | US6727364 Antiinflammatory agents |
| 04/27/2004 | US6727281 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 04/27/2004 | US6727279 Central nervous system disorders |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727272 Leflunomide analogs for treating rheumatoid arthritis |
| 04/27/2004 | US6727268 Cyclooxygenase inhibitors; antipyretic, analgesic, antiinflammatory, and anticarcinogenic agents |
| 04/27/2004 | US6727266 Substituted tryptophan derivatives |
| 04/27/2004 | US6727258 Allosteric adenosine receptor modulators |